bluebird bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch bluebird bio and buy or sell other stocks, ETFs, and their options commission-free!About BLUE
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies.
CEODavid D. Meek
CEODavid D. Meek
Employees248
Employees248
HeadquartersSomerville, Massachusetts
HeadquartersSomerville, Massachusetts
Founded1992
Founded1992
Employees248
Employees248
BLUE Key Statistics
Market cap48.66M
Market cap48.66M
Price-Earnings ratio-0.24
Price-Earnings ratio-0.24
Dividend yield—
Dividend yield—
Average volume193.95K
Average volume193.95K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$28.60
52 Week high$28.60
52 Week low$3.20
52 Week low$3.20
Stock Snapshot
With a market cap of 48.66M, bluebird bio(BLUE) trades at $4.97. The stock has a price-to-earnings ratio of -0.24.
bluebird bio(BLUE) stock opened on 2025-12-13 at —. The price climbed to — and dipped to —.
bluebird bio(BLUE) shares are trading with a volume of 0, against a daily average of 193.95K.
In the last year, bluebird bio(BLUE) shares hit a 52-week high of $28.60 and a 52-week low of $3.20.
In the last year, bluebird bio(BLUE) shares hit a 52-week high of $28.60 and a 52-week low of $3.20.
People also own
Based on the portfolios of people who own BLUE. This list is generated using Robinhood data, and it’s not a recommendation.